Skip to main content
2026 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Weiping Shao, PhD

Senior Director
Astrazeneca
Gaithersburg, Maryland

Dr. Weiping Shao is currently Sr. Director and Head of US GxP Testing Laboratories at AstraZeneca, where he leads regulated bioanalysis and scientific innovation to support the development of biologics modalities from pre-clinical to clinical across all therapeutic areas. Weiping brings more than 20 years of experience and leadership in pharmaceutical / biotech industry, including his previous role as Vice President and Head of Biologics Services at a global CRO, Director and Head of Bioanalytical Operations at Regeneron Pharmaceuticals, Inc and Research Fellow at Merck. He has built and led cross-functional organizations that support biologics development, bioanalytical services and biomarker discovery. Weiping has published over 40 peer reviewed manuscripts/ commentaries, filed US patents and co-authored industry Best Practices. He holds leadership roles at ISBER organization, chairs conferences and has given numerous presentations. He earned his Ph.D. from Nanjing University and completed his post-doctoral Fellowship in Biochemistry at University of California, San Diego.

Disclosure information not submitted.

Presentation(s):